Cortical amaurosis and status epilepticus with acute porphyria;Kortikale amaurosis und status epilepticus bei akuter porphyrie

Nervenarzt

Volumn 76, Issue 8, 2005, Pages 992-998

  Wessels, T ^a   Blaes, F ^a   Rottger C ^a   Hugens M ^a   Huge S ^a   Jauss, M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute intermittent porphyria; Cortical blindness; Magnetic resonance imaging; Seizure

Indexed keywords

BENZODIAZEPINE; GABAPENTIN; HEME ARGINATE; MIDAZOLAM; PHENYTOIN; PROPOFOL;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBRAL BLINDNESS; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EPILEPTIC STATE; EXTUBATION; FEMALE; GRAND MAL SEIZURE; HOSPITAL ADMISSION; HUMAN; INTUBATION; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; SEDATION; STATISTICAL SIGNIFICANCE; URINALYSIS; VISUAL IMPAIRMENT;

ACUTE DISEASE; ADULT; BLINDNESS, CORTICAL; FEMALE; HUMANS; PORPHYRIA, ACUTE INTERMITTENT; STATUS EPILEPTICUS;

EID: 23944511397     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1871-8     Document Type: Article

References (17)

1. Moore MR, Hift RJ (1997) Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol 43:89-94
2. Frank J, Christiano AM (1998) The genetic bases of the porphyrias. Skin Pharmacol Appl Skin Physiol 11:297-309
3. Lowenstein CJ, Snyder SH (1992) Nitric oxide, a novel biologic messenger. Cell 70:705-707
4. Lip GY, McColl KE, Moore MR (1993) The acute porphyrias. Br J Clin Pract 47:38-43
5. Bonkowsky HL, Schady W (1982) Neurologic manifestations of acute porphyria. Semin Liver Dis 2:108-124
6. Kupferschmidt H, Bont A, Schnorf H et al. (1995) Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 123:598-600
7. Lai CW, Hung TP, Lin WS (1977) Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination. Arch Neurol 34:310-312
8. Utz N, Kinkel B, Hedde JP et al. (2001) MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology 43:1059-1062
9. Celik M, Forta H, Dalkilic T et al. (2002) MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria. Neuroradiology 44:839-841
10. Seligman SP, Buyon JP, Clancy RM et al. (1994) The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171:944-948
11. Black KS, Mirsky P, Kalina P et al. (1995) Angiographic demonstration of reversible cerebral vasospasm in porphyric encephalopathy. AJNR Am J Neuroradiol 16:1650-1652
12. Hinchey J, Chaves C, Appignani B et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500
13. Mustajoki P, Nordmann Y (1993) Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 153:2004-2008
14. Poblete GP, Kunitz O, Wolff C et al. (2001) Diagnosis and treatment of the acute porphyrias: an interdisciplinary challenge. Skin Pharmacol Appl Skin Physiol 14:393-400
15. Moore MR, McColl KE (1989) Therapy of the acute porphyrias. Clin Biochem 22:181-188
16. Doss MO (2004) Arzneimittel bei akuten hepatischen Porphyrien und Empfehlungen zur Anästhesie. Rote Liste, Aulendorf/Württ
17. Solinas C, Vajda FJ (2004) Epilepsy and porphyria: new perspectives. J Clin Neurosci 11:356-361